The Michael J. Fox Foundation has awarded $1.5 million to six international research teams which are working on potentially disease-modifying therapies for Parkinson’s disease. The programme is financially supported by Elan Corporation Plc. ---Subscribe to MedNous to access this article--- Research & University News
